Results for this period
First quarter1 July 2026–30 September 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Solid demand supported by the increasing tendency to regard pets as family members, the aging of pets and growing health awareness among owners, together with the expansion of the veterinary hospital network, M&A, the strengthening of medical care systems at existing hospitals and appropriate revisions to medical care prices. In the medical and hygiene equipment business, increased selling, general and administrative expenses associated with upfront investment for future growth put downward pressure on segment profit.
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 July 2026–30 September 2026 |
| Net Sales | ¥1,695 million (YoY +24.2%) |
| Operating profit | ¥278 million (YoY +16.5%) |
| Ordinary income | ¥283 million (YoY +16.3%) |
| Profit attributable to owners of the parent | ¥191 million (YoY +15.8%) |
| Net income per share | ¥25.30 |
| Equity ratio | End of the current fiscal period 59.9 / End of previous period 54.7 |
| Total assets | ¥7,492 million |
| Net assets | ¥4,510 million |
| Full-year earnings forecast | Net Sales ¥7,535 million (YoY +22.4%) / Operating profit ¥1,569 million (YoY +39.3%) / Ordinary income ¥1,569 million (YoY +38.7%) / Net income ¥1,005 million (YoY +7.0%) |
| Annual Dividend Forecast | ¥0 → ¥26 |
| Segment revenue | Veterinary Hospital Network Business ¥1,479,696 thousand (YoY +110.9%), Medical and Hygiene Equipment Business ¥98,427 thousand, Biomaterials Business ¥6,229 thousand, Medical Data Solutions Business ¥31,822 thousand, Contract Research and Development Business ¥81,214 thousand |
| Segment profit | Veterinary Hospital Network Business ¥335,678 thousand (YoY +114.7%), Medical and Hygiene Equipment Business ¥-3,824 thousand, Biomaterials Business ¥1,035 thousand, Medical Data Solutions Business ¥5,620 thousand, Contract Research and Development Business ¥15,557 thousand |
| Depreciation and amortization | ¥47,580 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income No / Extraordinary loss Loss on disposal of fixed assets ¥0 thousand |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 2 / Company name メディトリックス株式会社, ノースワン株式会社 / Excluded Number of companies 0 / Company name Not disclosed |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | No |
| Issued Shares at Period-End | 7,974,000 shares |
| Treasury Shares at Period-End | 99,900 shares |
| Factors Behind Changes in Business Performance | Solid demand supported by the increasing tendency to regard pets as family members, the aging of pets and growing health awareness among owners, together with the expansion of the veterinary hospital network, M&A, the strengthening of medical care systems at existing hospitals and appropriate revisions to medical care prices. In the medical and hygiene equipment business, increased selling, general and administrative expenses associated with upfront investment for future growth put downward pressure on segment profit. |
Items this document does not state (12)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In addition to solid demand supported by the increasing tendency to regard pets as family members, the aging of pets and growing health awareness among owners, the Company expanded its veterinary hospital network, pursued M&A, strengthened the medical care systems at existing hospitals and appropriately revised medical care prices. In the medical and hygiene equipment business, selling, general and administrative expenses increased due to upfront investment for future growth, putting downward pressure on segment profit.